Earlier this month, ImmunityBio, Inc. reported third quarter and nine-month earnings, with revenue rising to US$32.06 million and US$75 million, alongside narrowing net losses compared to the prior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback